| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |